RxDoctor Payments Data

Troy Murphy, DO

Family Medicine · Savannah, GANPI 1639178395

Payments from drug & device makers

$5,483in general payments, 2019–2025

Across 335 payments — averaging $16.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AstraZeneca$694
  • Lilly USA, LLC$426
  • Astellas Pharma US Inc$420
  • Pfizer$397
  • Boehringer Ingelheim$290
  • plus $2K from 34 others

What the payments were for

  • Food & beverage$5,483100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,483 in reported general payments places this provider in the 85th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$188,232
Medicare patients
382
Services billed
6,323

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide129$157,433
EliquisApixaban83$58,831
MounjaroTirzepatide46$49,247
JanuviaSitagliptin Phosphate21$31,547
Tresiba Flextouch U-100Insulin Degludec64$24,160
TrulicityDulaglutide19$21,480
XareltoRivaroxaban27$17,983
FarxigaDapagliflozin Propanediol22$16,301
TradjentaLinagliptin24$14,919
JardianceEmpagliflozin21$11,917
Janumet XrSitagliptin Phos/Metformin Hcl21$10,826
GlyxambiEmpagliflozin/Linagliptin11$7,932
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,606
Combivent RespimatIpratropium/Albuterol Sulfate15$7,179
Atrovent HfaIpratropium Bromide14$6,622

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,079$157,433129 claims
Lilly USA, LLCMounjaro, Trulicity$426$70,72765 claims
PfizerEliquis$397$58,83183 claims
MerckJanuvia, Janumet Xr$15$42,37342 claims
Boehringer IngelheimTradjenta, Jardiance, Glyxambi, Combivent Respimat$290$41,94771 claims
AstraZenecaFarxiga, Breztri Aerosphere$694$23,90734 claims
Johnson & JohnsonXarelto$72$17,98327 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$43$2,700301 claims
AbbVieSynthroid$218$1,60932 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Savannah

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →